Contact
Please use this form to send email to PR contact of this press release:
UbiVac to present on Dark Genome-derived Dark Matter/Proteome Cancer Immunotherapy at Spring 2025 Venture Forum
TO:
Bernard A Fox, PhD
UbiVac
+1 971-413-7139